 | Clinical activity of rituximab in extranodal
marginal zone B-cell lymphoma of MALT type.
Blood. 2003 Oct 15;102(8):2741-5. Epub 2003 Jul
03. PMID:
12842999 | Related
abstracts
Lay perspective: These findings
suggest that Rituxan should be given full consideration as treatment for MALT
prior to chemotherapy.
|
| Managing Infections in Patients With Hematologic Malignancies
Content Development Co-Chairs: Kenneth V. Rolston, MD, John R. Wingard, MD -
Medscape 2003
(free login req.)
|
| Immunomedics in Discussions to Regain Development Rights From Amgen for Epratuzumab
(anti-cd22) - stockworld
|
| Rituxan failed to show improved survival as a maintenance therapy in aggressive NHL. -
November 10, 2003 - commentwire.com
|
| ViaCell Initiates Phase I/II Trial of Amplified
Cord Blood Stem Cells as Therapy for Adults with Leukemia and
Other Hematologic Cancers - viacellinc.com
|
| A phase I single-dose trial of gadolinium
texaphyrin (Gd-Tex), a tumor selective radiation sensitizer
detectable by magnetic resonance imaging.
Clin Cancer Res. 1999 Apr;5(4):739-45. PMID:
10213207 | Related
abstracts
This item is not lymphoma-specific, but bears watching because of
the potential it has to be taken up selectively in tumor cells,
it's short half life, and because uptake can be verified by MR
imaging.
|
| Methotrexate Induction Therapy Followed by High-Dose Chemotherapy ...
Doctor's Guide ... followed by high-dose chemotherapy with autologous stem-cell rescue
may be a feasible treatment approach for primary central nervous system
(CNS) lymphoma ... - docguide.com
(press release)
|
| Cigarette Smoking in Women Increases Risk for
Follicular Lymphoma.
United States Researchers from Yale University have reported that
long-term cigarette smoking in women increases the risk of
developing follicular lymphoma. - cancerconsultants.com
|
|
|
| Clinical Anti-Cancer ... PPI-2458 (targeting
MetAP2) has recently entered a Phase I clinical study for the treatment
of NHL at the Dana-Farber Cancer Institute, in Boston, MA.- businesswire |
Related
abstracts
|
| Localized Mucosa-Associated Lymphoid Tissue
Lymphoma Treated With Radiation Therapy Has Excellent Clinical
Outcome. J Clin Oncol. 2003 Nov
15;21(22):4157-4164. PMID:
14615444
|
| Study Links Psoriasis to Lymphoma Cancers
Yahoo News CHICAGO (Reuters) - Psoriasis sufferers may later
develop lymphoma cancers
at nearly three times the rate of people who do not have the red
and scaly skin ... news.yahoo.com
|
| Primary Central Nervous System Lymphoma:
Results of a Pilot and Phase II Study of Systemic and
Intraventricular Chemotherapy With Deferred Radiotherapy. J Clin
Oncol. 2003 Nov 3
PMID:
14597744 | More
|
| PET imaging to predict responders and
non-responders to high dose condition therapy for SCT - hematology.org
|
| Will Medicare/Medicaid reimburse for Zevalin and Bexxar? Status of decision here.
Also how to make public comment about off-label use of these agents, which could be
very important to folks with MCL, and CLL/SLL, etc. - cms.hhs.gov
|
| HLA-matched unrelated donor hematopoietic cell
transplantation after nonmyeloablative conditioning for patients
with hematologic malignancies. Blood. 2003 Sep 15;102(6):2021-30.
Epub 2003 Jun 05. PMID:
12791654 | More
|
| Distinct gene expression profiles characterize the histopathological stages of disease in Helicobacter-induced mucosa-associated lymphoid tissue lymphoma
(full text) - PNAS
Feb_2003
|
|
Predicting response to Rituxan: Variation in gene expression patterns in follicular lymphoma and the response to rituximab -
Sean P. Bohen, Olga G. Troyanskaya, Orly Alter, Roger Warnke, David Botstein, Patrick O. Brown,
and Ronald Levy (full text) - PDF
|
| Overcoming drug resistance: Sensitization of ara-C-resistant
lymphoma cells by a SATE pronucleotide analogue. Int J
Cancer. 2003 Oct 20;107(1):149-54. PMID:
12925971 | Abstracts
|
|
|
|
New Protocol: Mitoxantrone-cyclophosphamide-rituximab: an effective and safe
combination for indolent NHL.
Hematol Oncol. 2003 Sep;21(3):99-108. PMID:
14579238
|
| Autoimmune cytopenia does not predict poor prognosis in chronic
lymphocytic leukemia/small lymphocytic lymphoma. Am J Hematol. 2003
Sep;74(1):1-8.
PMID:
12949883 | Abstracts
|
|
Stage III follicular lymphoma: long-term follow-up and patterns of
failure.
Int J Radiat Oncol Biol Phys. 2003 Nov 1;57(3):748-54. PMID:
14529780
|
|
Predictive value of early 18F-fluoro-deoxyglucose positron emission
tomography (PET) in chemosensitive relapsed lymphoma. Br J Haematol.
2003 Oct;123(2):282-7.
PMID:
14531910
|
|
Pegfilgrastim (Neulasta) for chemo-induced
neutropaenia - docguide.com
10_03
|
|
Alternation of epirubicin and mitoxantrone in CHOP-like regimens
retains efficacy and reduces overall toxicity in elderly patients with
high and intermediate grade non-Hodgkin lymphomas. Leuk Lymphoma. 2002
Dec;43(12):2319-24. PMID: 12613518
|
|
Avoiding in-flight colds - travel.nzoom.com
Also since it's flu season, a good time to review the Immunization
Guide
|
|
Selenium May Raise Skin Cancer Risk - Reuters.com
Oct_03
|
|
Bexxar® may Improve Survival in Autologous Stem Cell Transplants
for Follicular Lymphoma - cancerconsultants.com
|
| Stanford Research Builds Link between Sleep, Cancer Progression - sciencedaily.com
|
| Inex Pharmaceuticals initiates submission of New Drug Application
for Onco TCS to the United States FDA - newswire.ca
Oct_03
|
| Transimmunization - an investigational immunotherapy that utilizes photopheresis -
zwire.com
|
| Predicting response to Rituxan: Two Immunoglobulin G Fc Receptor
Polymorphisms (expressed on effector cells) Independently Predict
Response in Pts With Follicular NHL. J Clin Oncol. 2003 Sep 15 - PMID:
12975461
|
| Doctors' knowledge of radiation exposure: questionnaire study,
2003 - BMJ
|
| The Dual Association between Lymphoma and Autoimmunity - rheuma21st.com
|
|
|
| Multicenter study of pegylated liposomal doxorubicin in patients
with cutaneous T-cell lymphoma. Cancer. 2003 Sep 1;98(5):993-1001. PMID:
12942567
|
| Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma -
jem.org 9_15_03
|
| Painkillers May Raise Lymphoma Risk for Women - paktribune.com 9_14_03
|
| Corixa wins full reimbursement for lymphoma drug (Bexxar) - Seattle Times 9-12_03
|
| Measuring the Benefits of Cancer Therapy - abcnews.go.com
|
| Preclinical: Fully human anti-MHC class II monoclonal antibody,
1D09C3, may have potent synergistic activity with Rituxan - press
release
|
| Mechanism Found that Weakens Caregivers' Immune Status:
Interleukin-6 associated with diabetes and other serious diseases - acs.ohio-state.edu
Jun_03
|
| Correlation of Tumor Radiation-Absorbed Dose with Response Is Easier to Find in Previously Untreated Patients
Kenneth F. Koral, PhD, Mark S. Kaminski, MD and Richard L. Wahl, MD - Journal of Nuclear Medicine
|
| Phase II study of alemtuzumab in chronic lymphoproliferative
disorders.
Cancer. 2003 Aug 15;98(4):773-8. PMID:
12910522 | Related
|
| Multicenter study of pegylated liposomal doxorubicin in patients
with cutaneous T-cell lymphoma. Cancer. 2003 Sep 1;98(5):993-1001. PMID:
12942567
|
| Results Never Reported for Many Large Cancer Trials
Loss of Information May Affect How Doctors Treat Patients ACS - 2003/08/15
|
| Dioxin emissions from a solid waste incinerator and risk of
non-Hodgkin lymphoma. Epidemiology. 2003 Jul;14(4):392-8. PMID:
12843761
|
| Clinical trials: Non-chemo Rituxan combination studies - ClinicalTrials.gov
|
| Fatigue and Quality of Life: Lessons from the Real World - The
Oncologist, Feb_003 The impact of fatigue on the quality of life of
oncology patients is substantial and under-recognized.
|
| Oncologists disagree about benefits of Internet to patients
- CA
Cancer J Clin 2003
|
|
Immunotherapy, Past Present and Future - medscape
(free login req.)
|
|
Immunotherapy w/ autoBMT - medscape
(free login req.)
|
|
Bispecific antibodies - novel investigative treatment for
refractory Hodgkin's disease - related
abstracts
|
|
Treatment of relapsed B-cell non-Hodgkin's lymphoma with a
combination of rituxan and G-CSF: final report on safety and
efficacy. Leukemia. 2003 Aug;17(8):1658-1664. PMID: 12886256 - PubMed
| Related
abstracts
|
|
Combretastatin, an antiangiogenic agent for NHL?- Related
PubMed abstracts
|
| Corixa and GlaxoSmithKline Announce Commercial Availability of
BEXXAR Therapeutic Regimen - businesswire
|
|
Comparison of autologous and allogeneic hematopoietic stem cell
transplantation for follicular lymphoma - Blood First Edition
Paper July 31, 2003 - Summary
|
|
Utility of surgical resection with or without radiation therapy in
patients with low-grade gastric mucosa-associated lymphoid tissue
lymphoma
Pier Luigi Zinzani, Monica Tani, Enza Barbieri, Vittorio Stefoni, Lapo
Alinari, Michele Baccarani - Haematologica.org
|
|
Rituximab therapy for follicular lymphoma: a comprehensive review of
it's efficacy as primary treatment, treatment for relapsed disease,
re-treatment and maintenance - Yossi Cohen, Philippe Solal-Céligny,
Aaron Polliack - abstract
| PDF
| PDF-Help 07_03
|
|
Potential role of pharmacogenomics (how genetics affects drug
metabolism) in reducing adverse drug reactions: a systematic
review. JAMA. 2001 Nov 14;286(18):2270-9. Review. PMID: 11710893 -
PubMed
| Related
abstracts
|
|
Treating Aggressive Non-Hodgkin's Lymphoma - Non-Hodgkin's
Lymphoma: Where Do We Stand Today? - John D. Hainsworth, MD - Medscape
2003 (free login req.)
|
|
Voluntary Death: A Comparison of Terminal Dehydration and
Physician-Assisted Suicide, Annals of Internal Medicine - ACP
|
|
Hyperactive stress response to interferon-alpha predicts development
of depression - ASCO
7_03
|
|
Interferon interacts with p53 to provide defense against cancer and
viruses - ASCO
7_03
|
|
Treatment of advanced mycosis fungoides by allogeneic stem-cell
transplantation with a nonmyeloablative regimen. Bone Marrow Transplant.
2003 Apr;31(8):663-6. PMID: 12692606 - PubMed
|
|
RNA interference research is rapidly evolving, and the phenomenon
remains little-understood. But what is known is that these
double-stranded snippets effectively silence targeted genes. And that
makes the experts optimistic. - Health
AP 7_03
|
|
Expression of the granzyme B inhibitor, protease inhibitor 9, by
tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel
protective mechanism for tumor cells to circumvent the immune system? - bloodjournal.org
|
| Tumor-Starving Drugs Hit Their Stride -Researchers - Reuters
7_03
|
| Worry Over a Carcinogen (acrylamide) Spurs Research Blitz
- washingtonpost.com
7_03
|
| Inhibition of the proteasome induces cell cycle arrest and
apoptosis in mantle cell lymphoma cells. Br J Haematol. 2003
Jul;122(2):260-8. PMID: 12846895 - PubMed
|
| Involved-field radiotherapy for advanced Hodgkin's lymphoma.
N Engl J Med. 2003 Jun 12;348(24):2396-406. PMID: 12802025 - PubMed
|
| Guidance for Industry and FDA - Interim Evidence-based Ranking System for Scientific Data -
fda.gov
|
| Study: 1 in 3 doctors hides options - Physicians withhold
information on treatment choices -
MSN.com 7_03
|
| FDA Acts to Provide Better Information to Consumers on Trans
Fats - FDA.gov
Note: trans fats are also associated with increased risk of NHL in
women.
|
| Profiling cancer to find better treatments - sfgate.com
|
|
Non-Hodgkin's Lymphoma: The Evolution of Therapy - Medscape (free login req.) 07_03_03
|
|
FDA Approves Bexxar in Patients With Follicular Non-Hodgkin's
Lymphoma - DoctorsGuide
6_03 | ODAC
transcripts - PDF
|
|
|
| ASCO 2003 - 105 Lymphoma abstracts - Lymphomation.org
|
|
Untangling the Roots of Cancer - Sci
Amer. 07_03
|
|
Ocular Adnexal Lymphomas Linked to Chlamydia psittaci Infection -
common in pet birds - May respond to antibiotic treatment- ASCO
2003
|
|
NCI and FDA Announce Joint Program to Streamline Cancer Drug Development -
Cancer.gov 5_30_03
|
|
Gene profiles predict survival - NCS
Infoservices, 04_02
The activity of as few as 17 genes can be used to predict lymphoma patients' response to treatment, scientists reported at the 18th UICC International Cancer Congress in Oslo this week.
|
|
Management Strategies for Chronic Lymphocytic Leukemia CME Author: Michael J. Keating, MB, BS -
Medscape (free login req.) 06_03
|
|
|
|
Medicare Changes Coming? Some in Congress Say "Yes" - ACS
|
| DNA arrays diagnose, predict survival for Sezary syndrome cancer patients -
New technology validated, dozens of potential drug targets identified -
Eurekalert.org
Jun_03
|
| ASCO 2003 - Report on ONTAK (denileukin diftitox)
- biologic activity in CLL; how patients tolerated
treatment - BusWire
|
| Millennium says anti-cancer proteasome inhibitor safe over
longer term - ASCO
|
| ASCO 2003 - Oncophage (for indolent fNHL) in
the Phase II trial, there were responses observed ... suggesting
the potential utility of the vaccine in patients with minimal residual
disease. BusWire
|
| ASCO 2003 - SGN-30 is a genetically engineered antibody in clinical trials for the treatment of patients with CD30+ hematologic malignancies such as Hodgkin's disease, anaplastic large cell lymphoma and other types of lymphomas. -
Buswire
|
| ASCO 2003 - In Vitro Studies Demonstrate
GCS-100 Induces Cancer Cell Death By Mechanism Similar To Approved
Chemotherapies - BusWire
|
| High-dose radioimmunotherapy (Bexxar) versus conventional
high-dose therapy and autologous hematopoietic stem cell
transplantation for relapsed follicular non-Hodgkin's lymphoma: a
multivariable cohort analysis. Blood. 2003 May 15 PMID: 12750161 - PubMed
|
| New Therapeutic Strategies in Chronic Lymphocytic Leukemia (CLL)
- MDACC
Vol. 8, No. 2, Spring 2003
|
| Emerging Immunotherapies for Non-Hodgkin Lymphomas: The Tortoise
Approaches the Finish Line - Oliver W. Press, MD,
PhD - annals.org
|
| FDA Approves Velcade (PS-341) for Multiple Myeloma Treatment - FDA.gov
5_13_03 -- The FDA today announced the approval of Velcade (bortezomib)
injection, a new treatment for multiple myeloma, a cancer of the bone
marrow. FDA reviewed the application for this drug in less than four
months. Velcade is the first in a new class of anticancer agents known
as proteasome inhibitors.
|
| Ethics of clinical trials from a bayesian and decision analytic
perspective:
whose equipoise is it anyway? - BMJ
2003;326:980-981
|
| Future of Monoclonal Antibodies in the Treatment of Hematologic
Malignancies - Medscape
(free login req.)
|
| Picture A Cure: Putting A Face On Cancer - ACS Advocacy Action
"what if you could combine the ease of writing a letter with the impact of meeting face-to-face? You can through our advocacy tool “Picture A Cure.”
|
| Would a clinical trial be appropriate for me? Questions for
your doctor. A free printable brochure prepared by Patients
Against Lymphoma - PDF | PDF-Help
|
| Harmonizing Research and
Treatment Goals - Lymphomation.org
|
| Doctors aim to end conflicts of interest - Cancer specialists issue new guidelines
- Houston
Chronical
4_03
|
| Anti-CD40 monoclonal antibody therapy in combination with
irradiation results in a CD8 T-cell-dependent immunity to B-cell
lymphoma.
Blood. 2003 Apr 24 [epub ahead of print] PMID: 12714523 - PubMed
|
| Extranodal marginal zone B-cell lymphoma of mucosa-associated
lymphoid tissue of the head and neck area. Cancer. 2003 May
1;97(9):2236-41.
PMID: 12712477 - PubMed
|
| Technique Brings Immune-Based Therapies Closer To Reality -
hopkinsmedicine.org
"... inexpensive, reliable way to make large quantities of targeted immune cells"
|
| Prodigiosin induces apoptosis of B and T cells from B-cell
chronic lymphocytic leukemia. Leukemia. 2003 Apr;17(4):746-50. PMID:
12682632 - PubMed
|
| Gene profiling shows promise in diagnosis of cancer - sunspot.net
|
|
|
| HCV (hepatitis C virus) Infection Linked to Non-Hodgkin's Lymphoma Risk in U.S. -
Medscape (free login req.) Apr_03
|
| Review of :"Long-term remission in mantle-cell lymphoma following high-dose sequential chemotherapy and in vivo
rituxan-purged stem cell autografting (R-HDS regimen)" Blood - Docguide.com 4_4_03
|
| Rituximab plus chemotherapy in follicular and mantle cell
lymphomas.
Semin Oncol. 2003 Feb;30(1 Suppl 2):16-20. Review. PMID: 12652460 - PubMed
|
| Variation in gene expression patterns in follicular lymphoma and
the response to rituximab. Proc Natl Acad Sci U S A. 2003 Feb
18;100(4):1926-30.
PMID: 12571354 - PubMed
|
| Getting a Second Opinion > James Armitage, MD - CureToday.com
|
| 4-year data: Safety of Yttrium-90 Ibritumomab Tiuxetan
Radioimmunotherapy for Relapsed Low-Grade, Follicular, or Transformed
Non-Hodgkin's Lymphoma. J Clin Oncol. 2003 Apr 1;21(7):1263-70. PMID:
12663713 - PubMed
|
| FDA Approves New Drug to Combat Nausea and Vomiting for Cancer Patients Getting Chemotherapy -
FDA
03_26_02
|
| The immune system: a target for functional foods? Br J Nutr.
2002 Nov;88 Suppl 2:S165-77. Review. PMID: 12495459 - PubMed
|
|
Preparative regimens of thymoglobulin beneficial for marrow transplant
patients - Preparative regimen found to reduce risk of acute and chronic
GVHD.
- hemonctoday.com
03_03
|
|
Making sure the chemo isn't worse than the cancer - Doctors seek a way to customize treatment for each patient
- seattlepi.com
"How you metabolize (the drug) is a clear predictor of
whether you are in the 10 to 15 percent of people with organ damage"
|
|
Nonmyeloablative (mini) Allogeneic Stem-Cell Transplantation for Hematologic Malignancies: A Systematic Review
from Cancer Control: Journal of the Moffitt Cancer Center - Medscape (free login req.) 3_5_03
|
|
Old drugs bring new cancer hope 03_11_03 - Health Newswire
"Two drugs [clofibric acid, and medroxyprogesterone acetate] have been found to kill cancer cells, which could lead to a breakthrough in the treatment of a particularly aggressive form of blood cancer [Burkitt's lymphoma], according to UK
researchers."
|
|
Public Attitudes Toward Participation in Cancer Clinical Trials
Robert L. Comis, Jon D. Miller, Carolyn R. Aldigé, Linda Krebs, Ellen Stoval -
jco.org
Journal of Clinical Oncology, Vol 21, Issue 5 (March), 2003
"Conclusion: ... the primary problem with accrual is not the attitudes of patients, but rather that the loss of potential participants is the result of the unavailability of an appropriate clinical trial and the disqualification of large numbers of patients. The pool of willing patients is further reduced by the reluctance of some physicians to engage in accrual.
"
|
|
FDA toughens stance on Canadian imports - ReutersNew
03_13_03
|
|
Ricin cancer therapy to be tested to treat lymphoma - BBC News 3_11_03
|
|
Organically Grown Foods Higher In Cancer-fighting Chemicals Than Conventionally Grown Foods -
American Chemical Society
3_04_03
|
|
Neuroprotective effect of vitamin e supplementation in patients
treated with Cisplatin chemotherapy. J Clin Oncol. 2003 Mar
1;21(5):927-31. PMID: 12610195 - PubMed
|
|
Treatment-Related Myelodysplasia and Acute Leukemia in
Non-Hodgkin's Lymphoma Patients. J Clin Oncol. 2003 Mar
1;21(5):897-906.
PMID: 12610191 - PubMed
|
|
Treatment of cutaneous T cell lymphoma: current status and future directions. Am J Clin
Dermatol. 2002;3(3):193-215. Review.
PMID: 11978140 - PubMed
| Reader-friendly
|
|
Radiation link to cancer explained - BBC
2_27_03
|
|
Drug response linked to genes in lymphoma patients - GNN
2_21_03
"The researchers identified about 150 genes in lymph tumors that could help predict the drug response. The activity of these genes differed significantly between patients who responded to treatment and those who did not.
"
|
|
|
|
Trans fat lurks in a multitude of foods. It’s not labeled. And it’s bad for your heart. Here’s how to avoid it.
- ComsumerReports.org
02_23_03
|
|
Cancer in the Home: - Healthology
at Lymphomation.org
A "New Normal" Part One Interview with
Dr. Wendy Harpham
|
|
Cancer in the Home: - Healthology
at Lymphomation.org
Recurring Hope, Part Two Interview with Dr. Wendy
Harpham
|
|
Toxic neuropathy in patients with pre-existing neuropathy.
Neurology. 2003 Jan 28;60(2):337-40. PMID: 12552058 - PubMed
|
|
Study finds fruit reduces risk of cancer - The
Guardian 02_20_03
|
|
Lack of serological evidence for an association between simian
virus 40 and lymphoma. Int J Cancer. 2003 Apr 10;104(4):522-4. PMID:
12584752 - PubMed
/ Serology - A blood test that detects the presence of antibodies to
a particular antigen
|
|
Complete remission of tumour with interleukin 2 therapy in a
patient with non-Hodgkin's lymphoma post allogeneic bone marrow
transplant associated with polyclonal T-cell bone marrow
lymphocytosis.
Br J Haematol. 2003 Feb;120(3):523-525. PMID: 12580972 - PubMed
|
|
Rituximab plus CHOP (R-CHOP) overcomes bcl-2-associated resistance
to chemotherapy in elderly patients with diffuse large B-cell lymphoma
(DLBCL). Blood. 2003 Feb 6 PMID: 12576316 - PubMed
|
|
Record Number of Cancer Cases Predicted - HealthScoutNews 02_12_03
|
|
Transplant May Help Incurable Lymphomas - Less Toxic Treatment Appears to Cure Some Patients -
ACS 01_22_03
|
|
Pre-clinical
testing HuMax-CD20 appears to kill tumor cells resistant to rituximab
- Genmab
(drug sponsor)
|
| CHOP: Dose Intensive and Dose Dense CHOP Regimens - Abstracts & Commentary -
CTCLconsult.com 02_01_03
"Even if these dose-dense or intense regimens were to show some
advantage they would not be appropriate for a large proportion of
patients who are either older or have significant comorbid illness."
|
| A User’s Manual For The IOM’s ‘Quality Chasm’ Report
PDF
| PDF-Help
"the Quality Chasm report has attracted much less public attention than
"To Err Is Human" did, but for the serious student of health care quality and the serious leader of needed change, it signals the possible dawning of a new and persistent sense that the U.S. health care system’s performance in many dimensions, not just safety, is unacceptably far from what it should be."
|
| BCL-2 Expression Predicts Poor Outcome in Classical Hodgkin's Disease - Will Boggs, MD -
Medscape (free login req.) 02_01_03
|
| Thalidomide-Like Drug Has Potential to Fight Cancer - ReutersNew 02_03_03
|
| Radiotherapy blow to fertility underestimated Eggs twice as sensitive to cancer-treating radiation.
- Nature.com 01_31_03
|
| Regimen Tailored to Elderly Patients Shows Promise Against NHL -
Medscape (free login req.) 02_01_03
|
| Irinotecan in Relapsed or Refractory Non-Hodgkin’s Lymphomas, Vol 16, No 8, Suppl 7 (August 2002) -
cancernetwork.com
|
| Drug Sales Bring Profits, and Scrutiny, to Cancer Doctors - NYTimes
01_26_03 (free login req.)
|
| Shared decision making - Who Decides? But the answer is not so obvious anymore; it is confounded by other questions: Whose preferences matter more? In situations of uncertainty about the best way to manage a given condition, whose preferences should prevail? Are more care, more intervention, more hospitalization and more screening better than less? - James N. Weinstein, DO, MS
AAOS
|
| Well-Informed Patients Consider Joining Clinical Trials
Physicians Should Seek to Explain Benefits Whenever Possible ACS 8_29_01
If more physicians worked to increase their patients’ awareness about the value of clinical trials, participation might increase and help advance treatments for cancer, according to new research on patient attitudes about such studies, published in the August Journal of Clinical Oncology (Vol. 19, No. 15: 3554-3561).
|
| Report Supports Association Between Agent Orange and CLL
"A re-evaluation of evidence now supports an association between exposure to herbicides used during the Vietnam War and the development of a specific form of leukemia in
veterans" - IOM - nationalacademies.org
|
| Too much vitamin A boosts risk of broken bones - ReutersNew 1_22_03
|
| Two-weekly CHOP with G-CSF: New Standard Regimens for Elderly Patients with Aggressive Non-Hodgkin's
Lymphoma - mednet.ca
"Finally, it appears that improvements on CHOP21 for the elderly are
emerging from different directions. One approach involves the delivery of
CHOP cycles over the shorter period of 14 days with granulocyte-colony
stimulating factor (G-CSF) support (CHOP14G), while the other adds the
anti-CD20 monoclonal antibody rituximab to CHOP21 (R-CHOP21)."
|
| Prolonged single-agent versus combination chemotherapy in
indolent follicular lymphomas: a study of the cancer and leukemia
group B.
J Clin Oncol. 2003 Jan 1;21(1):5-15. PMID: 12506163 - PubMed
|
| Review Notes Medical Research Conflicts - abcnews
1_21_03
|
| Measuring health-related quality of life in clinical trials that evaluate the role of chemotherapy in cancer treatment,
Michael Michael, MB, BS; Ian F. Tannock MD, PhD - CMAJ
|
| France Boosts Campaign Against Cancer - ReutersNew
1_17_03
|
| Canadian Federal government derelict in fighting cancer: group -
CBC 1_17_03
|
| Man turns to tobacco to cure cancer - Los Angeles Times
Jan_07_03
|
|
Gene (HGAL) identified that strongly predicts survival in
diffuse large B-cell lymphoma. Blood 2003; 101: 433-40.. - PubMed
|
|
Reovirus Therapy Demonstrates Activity Against Lymphoid
Malignancies - Medscape
(free login req.) 01_07_03
|
|
Biotech Survives Its Toughest Year
Ever - PRNewswire
01_03
|
